Literature DB >> 26175951

A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.

Huabang Zhou1, Xiaolan Jiang1, Qiaomei Li1, Jingyi Hu2, Zhengrong Zhong3, Hao Wang1, Hui Wang1, Bing Yang1, Heping Hu1.   

Abstract

UNLABELLED: Incidence and mortality of intrahepatic cholangiocarcinoma (ICC) are increasing. However, its prognostic predictive system associated with outcome after surgery remains poorly defined. In this study, we conducted retrospective survival analyses in a primary cohort of 370 patients who underwent partial hepatectomy for ICC (2005 and 2009). We found that seven variables were significantly independent predictors for overall survival (OS): serum prealbumin (hazard ratio [HR]: 1.447; p = 0.015), carbohydrate antigen 19-9 (HR: 1.438; p = 0.009), carcinoembryonic antigen (HR: 1.732; p = 0.002), tumor number (HR: 1.781; p < 0.001), vascular invasion (HR: 1.784; p < 0.001), regional lymphatic metastasis (HR: 2.003; p < 0.001) and local extrahepatic metastasis (HR: 1.506; p = 0.008). Using these independent predictors, we created a simple clinicopathologic prognostic staging system for predicting survival of ICC patients after resection. The validity of the prognostic staging system was prospectively assessed in 115 patients who underwent partial hepatectomy between January 2010 and December 2010 at the same institution. The prognostic power was quantified using likelihood ratio test and Akaike information criteria. Compared with the 6(th) and 7(th) AJCC staging systems, the new staging system in the primary cohort had a higher predictive accuracy for OS in terms of homogeneity and discriminatory ability. In the validation cohort, the homogeneity and discrimination of the new staging system were also superior to the two other staging systems.
CONCLUSIONS: The new staging system based on clinicopathologic features may provide relatively higher accuracy in prognostic prediction for ICC patients after tumor resection.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma; clinicopathologic features; partial; prognosis; staging system

Year:  2015        PMID: 26175951      PMCID: PMC4497449     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  42 in total

1.  Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.

Authors:  Shinichi Aishima; Yousuke Kuroda; Yunosuke Nishihara; Tomohiro Iguchi; Kenichi Taguchi; Akinobu Taketomi; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  2007-07       Impact factor: 6.394

Review 2.  Intrahepatic cholangiocarcinoma: management options and emerging therapies.

Authors:  Rebecca M Dodson; Matthew J Weiss; David Cosgrove; Joseph M Herman; Ihab Kamel; Robert Anders; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-07-24       Impact factor: 6.113

3.  Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer.

Authors:  Hideki Kawai; Hideki Ota
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

4.  A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Authors:  S Chevret; J C Trinchet; D Mathieu; A A Rached; M Beaugrand; C Chastang
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

5.  Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.

Authors:  Hua-Bang Zhou; Hui Wang; Yu-Qiong Li; Shuang-Xi Li; Hao Wang; Dong-Xun Zhou; Qian-Qian Tu; Qing Wang; Shan-Shan Zou; Meng-Chao Wu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

6.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 8.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

Review 9.  Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis.

Authors:  Kwang-Yu Chang; Jang-Yang Chang; Yun Yen
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

10.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

View more
  8 in total

1.  Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.

Authors:  John R Bergquist; Tommy Ivanics; Curtis B Storlie; Ryan T Groeschl; May C Tee; Elizabeth B Habermann; Rory L Smoot; Michael L Kendrick; Michael B Farnell; Lewis R Roberts; Gregory J Gores; David M Nagorney; Mark J Truty
Journal:  J Surg Oncol       Date:  2016-07-20       Impact factor: 3.454

Review 2.  Staging of intrahepatic cholangiocarcinoma.

Authors:  Sean M Ronnekleiv-Kelly; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

3.  A model for predicting post-liver transplantation recurrence in intrahepatic cholangiocarcinoma recipients.

Authors:  Ao Ren; Zhongqiu Li; Xuzhi Zhang; Ronghai Deng; Yi Ma
Journal:  J Gastrointest Oncol       Date:  2020-12

4.  Prognostic Value of Pretreatment Serum Transthyretin Level in Patients with Gastrointestinal Cancers.

Authors:  Hongliang Luo; Jun Huang; Zhengming Zhu; Peiqian Zhu
Journal:  Dis Markers       Date:  2019-06-03       Impact factor: 3.434

5.  High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.

Authors:  Chao Bi; Mei Liu; Weiqi Rong; Fan Wu; Yang Zhang; Shengtao Lin; Yunhe Liu; Jianxiong Wu; Liming Wang
Journal:  BMC Cancer       Date:  2019-03-08       Impact factor: 4.430

6.  A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data.

Authors:  Zhizhen Li; Lei Yuan; Chen Zhang; Jiaxing Sun; Zeyuan Wang; Yu Wang; Xin Hao; Fei Gao; Xiaoqing Jiang
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

7.  Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma.

Authors:  Fabian Bartsch; Lisa-Katharina Heuft; Janine Baumgart; Maria Hoppe-Lotichius; Rabea Margies; Tiemo S Gerber; Friedrich Foerster; Arndt Weinmann; Beate K Straub; Jens Mittler; Stefan Heinrich; Hauke Lang
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

8.  Long-term outcome and prognostic nomogram for intrahepatic cholangiocarcinoma after thermal ablation: a retrospective study.

Authors:  Yang Wang; Zhuhui Yuan; Bozhi Liu; Hui Chen; Tian Yin; Jiasheng Zheng; Wei Li
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.